By Eva Richardson – The Logistic News | March 28, 2025
The global healthcare logistics landscape is undergoing a significant transformation, with the plasma and blood product logistics market projected to nearly double in value within the next decade. According to newly released research, the market is expected to grow from USD 99.89 billion in 2025 to USD 186.14 billion by 2032, representing a compound annual growth rate (CAGR) of 9.3%.
This remarkable surge is driven by a combination of factors, including the growing global demand for plasma-derived therapies, advances in temperature-sensitive supply chain technologies, and a shift toward precision medicine.
A Critical Link in Modern Healthcare
Plasma and blood products are among the most delicate materials handled in the global logistics network. Their transport requires strict temperature controls, real-time monitoring, and efficient customs clearance protocols, especially when moving between international biopharmaceutical hubs.
With plasma-based treatments gaining momentum in addressing conditions like autoimmune disorders, hemophilia, and immunodeficiencies, the pressure on logistics networks has intensified. The industry’s response has been to expand cold chain capabilities and embrace more sophisticated tracking systems, ensuring the viability and safety of life-saving therapies.
Driving Market Segments
The market is segmented into cold chain and non-cold chain logistics, with cold chain dominating due to the sensitive nature of most plasma and blood products. Logistics providers are also diversifying their offerings across shipping methods—airfreight, sea freight, and overland—and expanding warehousing infrastructure for more efficient regional distribution.
Healthcare organizations—ranging from biopharma companies and contract manufacturers to biobanks—form the bulk of demand for specialized logistics services, pushing providers to adopt high-compliance, scalable solutions.
Strategic Players and Regional Growth
Logistics giants such as DHL, Kuehne+Nagel, DB Schenker, UPS, CEVA Logistics, and Maersk are leading the charge, investing heavily in infrastructure, sustainability, and digitization. Their focus on global reach and precision logistics is turning the sector into a cornerstone of healthcare resilience.
While North America and Europe continue to drive market revenue, Asia-Pacific and the Middle East are emerging as high-growth regions, spurred by expanding healthcare access and government investment in healthcare infrastructure.
Looking Ahead: Risk and Opportunity
Despite strong growth forecasts, challenges remain. Rising operational costs, regulatory complexities, and geopolitical instability could strain fragile supply routes. At the same time, new therapeutic developments and the rise of personalized medicine present opportunities for logistics firms to adapt and specialize further.
As the global health landscape evolves, plasma and blood product logistics are no longer a niche vertical, but a strategic pillar of the broader healthcare and life sciences ecosystem.
Eva Richardson
Senior Correspondent – The Logistic News
For updates on logistics innovation and supply chain transformation, follow us at The Logistic News.
